Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Saccharomyces boulardii does not prevent relapse of Crohn's disease.
Bourreille A, Cadiot G, Le Dreau G, Laharie D, Beaugerie L, Dupas JL, Marteau P, Rampal P, Moyse D, Saleh A, Le Guern ME, Galmiche JP; FLORABEST Study Group. Bourreille A, et al. Among authors: dupas jl. Clin Gastroenterol Hepatol. 2013 Aug;11(8):982-7. doi: 10.1016/j.cgh.2013.02.021. Epub 2013 Mar 1. Clin Gastroenterol Hepatol. 2013. PMID: 23466709 Clinical Trial.
Mapping of a susceptibility locus for Crohn's disease on chromosome 16.
Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G. Hugot JP, et al. Among authors: dupas jl. Nature. 1996 Feb 29;379(6568):821-3. doi: 10.1038/379821a0. Nature. 1996. PMID: 8587604
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, Duclos B, Soulé JC, Gendre JP, Galmiche JP, Danne O, Cadiot G, Lamouliatte H, Belaïche J, Mary JY. Modigliani R, et al. Among authors: dupas jl. Gastroenterology. 1996 Mar;110(3):688-93. doi: 10.1053/gast.1996.v110.pm8608877. Gastroenterology. 1996. PMID: 8608877 Clinical Trial.
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, Sarfaty E, Valleur P, Dupas JL, Daurat M, Faucheron JL, Lerebours E, Michot F, Belaiche J, Jacquet N, Soulé JC, Rothman N, Gendre JP, Malafosse M. Florent C, et al. Among authors: dupas jl. Eur J Gastroenterol Hepatol. 1996 Mar;8(3):229-33. doi: 10.1097/00042737-199603000-00008. Eur J Gastroenterol Hepatol. 1996. PMID: 8724022 Clinical Trial.
Clinical characteristics of Crohn's disease in 72 families.
Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Bélaïche J, Hostein J, Hugot JP, van Kruiningen H, Cortot A. Colombel JF, et al. Among authors: dupas jl. Gastroenterology. 1996 Sep;111(3):604-7. doi: 10.1053/gast.1996.v111.pm8780563. Gastroenterology. 1996. PMID: 8780563
Inflammatory bowel disease in spouses and their offspring.
Laharie D, Debeugny S, Peeters M, Van Gossum A, Gower-Rousseau C, Bélaïche J, Fiasse R, Dupas JL, Lerebours E, Piotte S, Cortot A, Vermeire S, Grandbastien B, Colombel JF. Laharie D, et al. Among authors: dupas jl. Gastroenterology. 2001 Mar;120(4):816-9. doi: 10.1053/gast.2001.22574. Gastroenterology. 2001. PMID: 11231934
[Recommendations for clinical practice for the treatment of ulcerative colitis: general method].
Godeberge P, Desreumaux P, Slim K, Dupas JL, Marteau P, Beaugerie L, Bouhnik Y, Flourié B, Gambiez L, Reimund JM, Seksik P. Godeberge P, et al. Among authors: dupas jl. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 2):951-3. doi: 10.1016/s0399-8320(04)95171-8. Gastroenterol Clin Biol. 2004. PMID: 15672565 Free article. French. No abstract available.
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.
Marteau P, Lémann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y, Cadiot G, Soulé JC, Bourreille A, Metman E, Lerebours E, Carbonnel F, Dupas JL, Veyrac M, Coffin B, Moreau J, Abitbol V, Blum-Sperisen S, Mary JY. Marteau P, et al. Among authors: dupas jl. Gut. 2006 Jun;55(6):842-7. doi: 10.1136/gut.2005.076604. Epub 2005 Dec 23. Gut. 2006. PMID: 16377775 Free PMC article. Clinical Trial.
298 results